The DOI matches its Crossref record; 89 of the 90 references it cites were found in a registry or an index; none of the 86 sources its claims cite is checked for support yet.
Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies
Abstract
Aims/hypothesis We systematically reviewed and summarised prospective data relating diabetes status to changes in cognitive function over time.Methods Published reports of longitudinal studies that described assessment of cognitive function in people with diabetes were sought. Studies were included if they assessed cognitive function in participants with diabetes at the beginning and at follow-up. Studies were excluded if they had (1) a follow-up period of less than 1 year, (2) a rate of loss to follow-up in excess of 30%, or (3) described selected subgroups. Change in cognitive function was recorded as either the mean change in score and/or the proportion of individuals developing various degrees of change in cognitive function. A pooled estimate was calculated for the latter.Results Of 1,165 abstracts and titles initially identified, 25 articles met the inclusion and exclusion criteria. Individuals with diabetes had a 1.2- to 1.5-fold greater change over time in measures of cognitive function than those without diabetes. When assessed by the Mini-Mental State Exam and the Digit Symbol Span tests, a diagnosis of diabetes increased the odds of cognitive decline 1.2-fold (95% CI 1.05-1.4) and 1.7-fold (95% CI 1.3-2.3), respectively . The odds of future dementia increased 1.6-fold (95% CI 1.4-1.8).Conclusions/interpretation Compared to people without diabetes, people with diabetes have a greater rate of decline in cognitive function and a greater risk of cognitive decline. Cognitive dysfunction should therefore be added to the list of chronic complications of diabetes.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This systematic overview of 25 prospective observational studies found that people with diabetes have greater cognitive decline and a higher risk of dementia than people without diabetes. The authors conclude that cognitive dysfunction should be added to the list of chronic complications of diabetes.
Key findings
- Among 25 included articles covering more than 8,656 people with diabetes and follow-up periods of 2 to 18 years, diabetes was associated with a 1.2- to 1.5-fold greater change over time in measures of cognitive function.
- Pooled estimates showed increased odds of cognitive decline on the MMSE/3MS (OR 1.2, 95% CI 1.05–1.4) and DSS (OR 1.7, 95% CI 1.3–2.3), and a 1.6-fold higher risk of future all-cause dementia (95% CI 1.4–1.8).
- For dementia subtypes, risks ranged from 1.2 to 2.3 for Alzheimer’s disease and from 2.2 to 3.4 for vascular dementia.
- In continuous DSS analyses, three studies reported a decline of 1.3 to 1.4% per year in people with diabetes; overall this decline was up to 1.5 times greater than in people without diabetes.
Methods
- Systematic review of longitudinal/prospective observational studies; Medline, EMBASE, and PsycINFO were searched, along with expert contact and bibliography review. Of 1,165 abstracts/titles, 50 were fully reviewed and 25 met inclusion/exclusion criteria.
- Inclusion required baseline and follow-up cognitive assessment, diabetes or glucose tolerance status, and English-language reporting; exclusions were follow-up under 1 year, loss to follow-up over 30%, or selected subgroups.
- Data were abstracted on age, diabetes definition, participant numbers, follow-up length, cognitive tools, and outcomes; pooled inverse variance-weighted log risk ratios with 95% CIs were calculated, with heterogeneity assessed by the Q statistic using Review Manager 4.2.
Limitations
- The paper states possible publication bias, though it argues this is unlikely because many included studies were prospective cohorts examining many risk factors; it also states that MMSE/3MS may underestimate diabetes effects because it poorly detects attention and processing speed.
- The paper states that included studies differed in definitions of clinically meaningful decline, diabetes identification, age groups, cognitive tools, statistical adjustment, baseline cognitive impairment, and follow-up completeness (73–92%), and that there is no evidence to date that diabetes management affects the rate or nature of cognitive dysfunction.
- Evident from the text: only three studies explicitly reported that data were collected without examiner awareness of diabetes status, and some pooled estimates relied on few studies, such as the DSS estimate based on two studies.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 86 cited sources checked · 0 supported · 0 flagged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Individuals with diabetes had a 1.2- to 1.5-fold greater change over time in measures of cognitive function than those without diabetes.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The odds of future dementia increased 1.6-fold (95% CI 1.4 -1.8).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Rests on an assumption: The definitions of dementia used in the included studies are sufficiently comparable to be combined in the review.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When assessed by the Mini-Mental State Exam and the Digit Symbol Span tests, a diagnosis of diabetes increased the odds of cognitive decline 1.2-fold (95% CI 1.05 -1.4) and 1.7-fold (95% CI 1.3 -2.3), respectively.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“The 25 remaining articles [46 -70] comprised data from more than 8,656 people with diabetes, with follow-up periods ranging from 2 to 18 years.”
What the sources say
- Not checked yetcites [46 -70]
Strength:plain· not yet calibratedn = 8,656Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When assessed by the Mini-Mental State Exam and the Digit Symbol Span tests, a diagnosis of diabetes increased the odds of cognitive decline 1.2-fold (95% CI 1.05 -1.4) and 1.7-fold (95% CI 1.3 -2.3), respectively.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“However, in contrast to the acute negative effect of hypoglycaemia on cognition, there is little evidence to support chronic cognitive impairment secondary to hypoglycaemia.”
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Compared to people without diabetes, people with diabetes were 1.2 times more likely to experience cognitive decline as measured by the MMSE/3MS (95% CI 1.0 -1.4) and 1.7 times more likely to experience cognitive decline as measured by the DSS (95% CI 1.3 -2.3).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Rests on an assumption: The cognitive assessment instruments used across the included studies measure cognitive decline in a comparable way.
None of the sources cited for this claim have been checked yet.
In the paper
“Table 2 lists the six studies that reported time-related changes as a continuous variable using either the MMSE or 3MS score in individuals with and without a history of diabetes [49, 51, 52, 54, 65, 69].”
What the sources say
- Not checked yetcites [49] Wu JH, Haan MN, Liang J, Ghosh D, Gonzalez HM, Herman WH (2003) Impact of antidiabetic medications on physical and cognitive functioning of older Mexican Americans with diabetes mellitus: a population-based cohort study. Ann Epidemiol 13:369–376 source
- Not checked yetcites [51] Fontbonne A, Berr C, Ducimetiere P, Alperovitch A (2001) Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 24:366–370 source
- Not checked yetcites [52] Haan MN, Shemanski L, Jagust WJ, Manolio TA, Kuller L (1999) The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 282:40–46 source
- Not checked yetcites [54] Gregg EW, Yaffe K, Cauley JA et al (2000) Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med 160:174–180 source
- Not checked yetcites [65] Hassing LB, Hofer SM, Nilsson SE et al (2004) Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study. Age Ageing 33:355–361 source
- Not checked yetcites [69] Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K (2004) Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 164:1327–1333 source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In these studies, diabetes status predicted an odds ratio for cognitive decline that ranged from 0.7 to 4.4.”
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Rests on an assumption: The cognitive assessment instruments used across the included studies measure cognitive decline in a comparable way.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Three studies reported a decline ranging from 1.3 to 1.4% per year in people with diabetes.”
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes
- Probably not a substantial claim. 12
- It may state two separate claims as one. 17
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of 1,165 abstracts and titles initially identified, 25 articles met the inclusion and exclusion criteria.”
- Also stated in: § Search · p. 3 · plain
“The 25 remaining articles [46 -70] comprised data from more than 8,656 people with diabetes, with follow-up periods ranging from 2 to 18 years.”
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
- Also stated in: § Search · p. 3 · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of these citations, 50 met the inclusion criteria and were fully reviewed and analysed.”
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The 25 remaining articles [46 -70] comprised data from more than 8,656 people with diabetes, with follow-up periods ranging from 2 to 18 years.”
Strength:plain· not yet calibratedn = 8,656Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Table 3, and Figs. 1 and 2 list and display results from the six studies that used the MMSE or 3MS [47 -51, 54, 62, 69] and the two studies that used the DSS [51, 54] to classify participants into those who did and did not experience cognitive decline.”
What the sources say
- Not checked yetcites [47] Nguyen HT, Black SA, Ray LA, Espino DV, Markides KS (2002) Predictors of decline in MMSE scores among older Mexican Americans. J Gerontol A Biol Sci Med Sci 57:M181–M185 source
- Not checked yetcites [48] Wu JH, Haan MN, Liang J, Ghosh D, Gonzalez HM, Herman WH (2003) Impact of diabetes on cognitive function among older Latinos: a population-based cohort study. J Clin Epidemiol 56:686–693 source
- Not checked yetcites [49] Wu JH, Haan MN, Liang J, Ghosh D, Gonzalez HM, Herman WH (2003) Impact of antidiabetic medications on physical and cognitive functioning of older Mexican Americans with diabetes mellitus: a population-based cohort study. Ann Epidemiol 13:369–376 source
- Not checked yetcites [50] Haan MN, Mungas DM, Gonzalez HM, Ortiz TA, Acharya A, Jagust WJ (2003) Prevalence of dementia in older Ltinos: the influence of type 2 diabetes mellitus, stroke and genetic factors. J Am Geriat Soc 51:169–177 source
- Not checked yetcites [51] Fontbonne A, Berr C, Ducimetiere P, Alperovitch A (2001) Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 24:366–370 source
- Not checked yetcites [54] Gregg EW, Yaffe K, Cauley JA et al (2000) Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med 160:174–180 source
- Not checked yetcites [62] Stewart R, Prince M, Mann A (2003) Age, vascular risk, and cognitive decline in an older, British, African-Caribbean population. J Am Geriat Soc 51:1547–1553 source
- Not checked yetcites [69] Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K (2004) Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 164:1327–1333 source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
In the paper
“However, one study reported an improvement in score of 1.2% in people with diabetes; nevertheless this improvement was approximately half of the improvement experienced by the non-diabetic participants [51].”
What the sources say
- Not checked yetcites [51] Fontbonne A, Berr C, Ducimetiere P, Alperovitch A (2001) Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 24:366–370 source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Four studies used the DSS as a continuous variable (Table 2) to assess cognitive function and three reported an adverse effect of diabetes on cognitive function over time.”
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Five of these studies reported that participants with diabetes had a higher risk of developing cognitive decline than those without diabetes; in three of these the lower limit of the 95% confidence interval exceeded 1 (i.e. it was statistically significant).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: The definitions of dementia used in the included studies are sufficiently comparable to be combined in the review.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Seventeen studies divided the participants into two groups based on whether or not participants did or did not experience cognitive decline during follow-up.”
Strength:plain· not yet calibratedn = 17Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Eight studies reported a variety of other cognitive tests, most of them reporting greater or equal cognitive change for the diabetic participants (Table 1) [46, 49, 51, 58, 63, 66, 69, 70]. Some, but not all of the tests detected a significant difference between the groups with and without diabetes.”
What the sources say
- Not checked yetcites [46] Logroscino G, Kang JH, Grodstein F (2004) Prospective study of type 2 diabetes and cognitive decline in women aged 70–81 years. BMJ 328:548 source
- Not checked yetcites [49] Wu JH, Haan MN, Liang J, Ghosh D, Gonzalez HM, Herman WH (2003) Impact of antidiabetic medications on physical and cognitive functioning of older Mexican Americans with diabetes mellitus: a population-based cohort study. Ann Epidemiol 13:369–376 source
- Not checked yetcites [51] Fontbonne A, Berr C, Ducimetiere P, Alperovitch A (2001) Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 24:366–370 source
- Not checked yetcites [58] Leibson CL, Rocca WA, Hanson VA et al (1997) Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol 145:301–308 source
- Not checked yetcites [63] Robertson-Tchabo EA, Arenberg D, Tobin JD, Plotz JB (1986) A longitudinal study of cognitive performance in noninsulin dependent (type II) diabetic men. Exp Gerontol 21:459–467 source
- Not checked yetcites [66] Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA (2004) Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 61:661–666 source
- Not checked yetcites [69] Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K (2004) Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 164:1327–1333 source
- Not checked yetcites [70] Yaffe K, Blackwell T, Kanaya AM, Davidowitz BA, Barrett-Connor E, Krueger K (2004) Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 63:658–663 source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In these studies, individuals with diabetes had a greater absolute annual decline in score than those without diabetes; however, the differences only achieved statistical significance in one study [70].”
What the sources say
- Not checked yetcites [70] Yaffe K, Blackwell T, Kanaya AM, Davidowitz BA, Barrett-Connor E, Krueger K (2004) Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 63:658–663 source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“The selected studies were analysed according to previously published methodological criteria [12] to determine if they reported: (1) a predetermined method for selection of the participants; (2) the definition of diabetes mellitus; (3) the definition of the outcome; (4) use of the same cognitive assessment instrument in the two groups; (5) that data were collected unaware of the diabetes status (b”
What the sources say
- Not checked yetcites [12] Horwitz RI, Feinstein AR (1979) Methodologic standards and contradictory results in case-control research. Am J Med 66:556–564 source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Only three studies explicitly reported that data were collected without the examiner being aware of the diabetes status of the participant [46, 51, 62].”
What the sources say
- Not checked yetcites [46] Logroscino G, Kang JH, Grodstein F (2004) Prospective study of type 2 diabetes and cognitive decline in women aged 70–81 years. BMJ 328:548 source
- Not checked yetcites [51] Fontbonne A, Berr C, Ducimetiere P, Alperovitch A (2001) Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 24:366–370 source
- Not checked yetcites [62] Stewart R, Prince M, Mann A (2003) Age, vascular risk, and cognitive decline in an older, British, African-Caribbean population. J Am Geriat Soc 51:1547–1553 source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Heterogeneity was assessed using the Q statistic [20].”
What the sources say
- Not checked yetcites [20] Laird NM, Mosteller F (1990) Some statistical methods for combining experimental results. Int J Technol Assess Health Care 6:5–30 source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“The validity of the MMSE as a screening tool for detecting dementia has been extensively studied [17]; its ability to detect changes in cognitive function for non-demented individuals has been documented mainly in the elderly [18].”
What the sources say
- Not checked yetcites [17] Tombaugh TN, McIntyre NJ (1992) The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 40:922–935 source
- Not checked yetcites [18] Brayne C, Spiegelhalter DJ, Dufouil C et al (1999) Estimating the true extent of cognitive decline in the old. J Am Geriatr Soc 47:1283–1288 source
Strength:boosted· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“ple with diabetes have a greater rate of decline in cognitive function and a greater risk of cognitive decline.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: The definitions of dementia used in the included studies are sufficiently comparable to be combined in the review.
- Rests on an assumption: The cognitive assessment instruments used across the included studies measure cognitive decline in a comparable way.
- Rests on an assumption: The included studies' participants with diabetes are representative of people with diabetes generally.
In the paper
“Compared to non-diabetic individuals, diabetes increased the risk of vascular dementia and Alzheimer ' s dementia 1.3 and 4.4-fold, respectively.”
What the sources say
- Not checked yetcites [72] Yamada M, Kasagi F, Sasaki H, Masunari N, Mimori Y, Suzuki G (2003) Association between dementia and midlife risk factors: the Radiation Effects Research Foundation Adult Health Study. J Am Geriat Soc 51:410–414 source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Experimental studies in animal models and in humans without diabetes have shown that poor glucose regulation after a glucose challenge test was associated with poorer performance on a variety of cognitive tests, the effect being more pronounced in the older age group [81].”
What the sources say
- Not checked yetcites [81] Messier C (2004) Glucose improvement of memory: a review. Eur J Pharmacol 490:33–57 source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Another factor suggesting that the reports underestimated the effect of diabetes on cognitive decline is the fact that most of the studies did not include information on people who died or who were lost to follow-up, when follow-up success itself could well be linked to good cognitive function.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“These findings are supported by previous reviews of the available longitudinal studies [3, 4, 6].”
What the sources say
- Not checked yetcites [3] Allen KV, Frier BM, Strachan MW (2004) The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations. Eur J Pharmacol 490:169–175 source
- Not checked yetcites [4] Areosa Sastre A, Grimley Evans J (2005) Effect of the treatment of Type II diabetes mellitus on the development of cognitive impairment and dementia. The Cochrane Library, Issue 2, http://www.cochrane.org/cochrane/revabstr/AB003804.htm
- Not checked yetcites [6] Stewart R, Liolitsa D (1999) Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med 16:93–112 source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Indeed, a recent review of the effect of therapy concluded that no studies were appropriate for inclusion in meta analysis [4].”
What the sources say
- Not checked yetcites [4] Areosa Sastre A, Grimley Evans J (2005) Effect of the treatment of Type II diabetes mellitus on the development of cognitive impairment and dementia. The Cochrane Library, Issue 2, http://www.cochrane.org/cochrane/revabstr/AB003804.htm
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
In the paper
“As these domains may be selectively impaired in people with diabetes the MMSE/3MS will underestimate the impact of diabetes on cognitive function [10].”
What the sources say
- Not checked yetcites [10] Strachan MW, Deary IJ, Ewing FM, Frier BM (1997) Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 20:438–445 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The study is also limited by the differences in the studies included with respect to: (1) the definition of a clinically meaningful decline in cognitive function; (2) identification of people with and without diabetes; (3) age groups that were studied; (4) cognitive assessment tools employed; (5) degree of statistical adjustment for confounders; (6) degree of cognitive impairment permitted in stud”
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In one study, this finding was only noted in young participants, while findings in older participants were consistent with the results from the other studies [62].”
What the sources say
- Not checked yetcites [62] Stewart R, Prince M, Mann A (2003) Age, vascular risk, and cognitive decline in an older, British, African-Caribbean population. J Am Geriat Soc 51:1547–1553 source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“However, many of the studies analysed by us were prospective cohort studies, which examined many risk factors for cognitive decline, and not just diabetes. This makes it unlikely that a lack of an association with diabetes would lead to non-publication.”
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In the other study, this finding was only noted for women, and only in certain cognitive tests. The large confidence interval and wide variability of scores between tests reported in this study suggest that a larger sample size could possibly have altered the results [69].”
What the sources say
- Not checked yetcites [69] Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K (2004) Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 164:1327–1333 source
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper relies on this without support.
The definitions of dementia used in the included studies are sufficiently comparable to be combined in the review.
“The definition of dementia used in each study was accepted for this review.”
The paper relies on this without support.
The cognitive assessment instruments used across the included studies measure cognitive decline in a comparable way.
“Cognitive function was measured using a variety of simple cognitive tests [9, 13, 14].”
The paper relies on this without support.
The included studies' participants with diabetes are representative of people with diabetes generally.
“The 25 remaining articles [46 -70] comprised data from more than 8,656 people with diabetes, with follow-up periods ranging from 2 to 18 years.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Older adults with diabetes are at higher risk of cognitive decline and institutionalization (12,13).”
From 13. Older Adults: Standards of Care in Diabetes—2024 (2024) · cites this paper as [12]
Experimental — accuracy not yet measuredIn the citing paper
“Type 2 diabetes (T2D) has been demonstrated to be related to accelerated cognitive decline (3) and increased risk of dementia (4)”
From Type 2 Diabetes and Antidiabetic Medications in Relation to Dementia Diagnosis (2014) · cites this paper as [3]
In the citing paper
“Cross-sectional studies have shown an association between hyperglycemia and cognitive dysfunction62.”
From Diabetes in Older Adults: A Consensus Report (2012) · cites this paper as [62]
In the citing paper
“Evidence for impairments in peripheral insulin signalling in patients with AD was presented more than 25 years ago, 138 and the incidence of AD is known to be increased in patients with metabolic impairments such as diabetes 139,140 ; fittingly, some cognitive domains have been consistently found to be affected in type 2 diabetes (eg, memory, psychomotor speed, executive function).113”
From Intranasal insulin (2021) · cites this paper as [139]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Fig. 3 non-diabetes-group total does not sum to its available counts
MinorThe four numerical non-diabetes-group counts displayed in Fig. 3 sum to 11,497, not the reported total of 10,044; the remaining study's count is marked NA.
Reported 10044 · recomputed 11497
“| Total (95% CI) | 2723 | 10044 | 1.6 (1.4, 1.8) |”
Gregg comparison-group count differs between Table 3 and Fig. 1
MinorFig. 1 lists 584 participants without diabetes for Gregg et al., whereas Table 3 lists 5,844 for the same study. The Fig. 1 total is consistent with 5,844, not 584.
“| Gregg et al [54] | 402 | 584 | 1.0 (0.8, 1.4) |”
“| MMSE/3MS | [54] | 65 - 99 (F) | History | 6 | 402 | 5844 | ≥ 11.5% a | 1.0 (0.8 - 1.4) e |”
Fig. 3 diabetes-group total does not sum to its study counts
MinorThe five diabetes-group counts displayed in Fig. 3 sum to 3,585, not the reported total of 2,723.
Reported 2723 · recomputed 3585
“| Total (95% CI) | 2723 | 10044 | 1.6 (1.4, 1.8) |”
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53221.x · Cited by 25,553
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,012
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J., & Wouters, E. (2015) · Gerontology · doi:10.1159/000430949 · Cited by 19,852
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. J. (2014) · Gerontology · doi:10.1159/000362720 · Cited by 19,007
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
The Mini‐Mental State Examination: A Comprehensive Review
Tombaugh, T. N., & McIntyre, N. J. (1992) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1992.tb01992.x · Cited by 5,152
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
The Prevalence of Comorbid Depression in Adults With Diabetes
Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.1069 · Cited by 3,926
Flagged first, then by citations
1 of the 90 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 701–800 of 998
Kim, J. S., Chun, B. C., & Lee, K. H. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1417236 · Cited by 5
Xiao, X., Chen, L., Liu, J., Cai, J., & Deng, M. (2025) · PeerJ · doi:10.7717/peerj.20292 · Cited by 4
“Elderly individuals with T2DM face an even higher risk, with a 1.5-to 2-fold increased likelihood of developing cognitive impairment compared to non-diabetic peers ( Cukierman, Gerstein & Williamson, 2005 ; Reuter-Lorenz & Cooke, 2016 ).”
InfluentialRole of Physiotherapy in Managing Type 2 Diabetes Mellitus
Kaur, N., & Singh, S. K. (2022) · Journal of Diabetology · doi:10.4103/jod.jod_48_22 · Cited by 4
Shapiro, A. L. B., Coughlan, C. M., Bettcher, B. M., PAULEY, M. E., Kim, J., Bjornstad, P., RAJIC, B. S., Truong, J., Bell, C., Choi, Y. J., et al. (2024) · Endocrines · doi:10.3390/endocrines5020014 · Cited by 5
“…were collected as follows: SEARCH baseline samples (Y-DM adolescent) were collected in 2003–2010, with a mean [SD] storage duration of 17 years [3]; SEARCH-4 samples (Y-DM young adults) were collected in 2016–2019, with a mean [SD] storage duration of 4 years [1]; EPOCH samples (control…”
BackgroundMethodInfluentialEffects of natural reduced water on cognitive functions in older adults: A RCT study
Shinada, T., Kokubun, K., Takano, Y., Iki, H., Kobayashi, K., Hamasaki, T., & Taki, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38505 · Cited by 4
Khan, F., Hussain, S., Singh, S., Sawlani, K. K., Usman, K., Sachan, A. K., & Khattri, S. (2025) · Cureus · doi:10.7759/cureus.77753 · Cited by 4
“In the long term, T2DM not only causes microvascular and macrovascular complications but also affects cognitive and psychological health [2].”
He, S., Lu, J., Wu, J., Zheng, M., Ma, J., Hua, X., & Xu, J. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149586 · Cited by 4
Sun, M., Wang, X., Lu, Z., Yang, Y., Lv, S., Miao, M., Chen, W., Wu, S., & Zhang, J. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16434 · Cited by 6
Perspectives for cognitive rehabilitation of patients with diabetes mellitus
Матвеева, М. В., Самойлова, Ю. Г., Жукова, Н. Г., Oleynik, O. A., & Rotkank, M. (2016) · Obesity and metabolism · doi:10.14341/omet201643-7 · Cited by 4
Traditional Herbal Remedies for Complications of Diabetes Mellitus
Mahajon, B. (2017) · doi:10.23959/sfjhm-1000004 · Cited by 4
“Other chronic complications of diabetes include depression [16], dementia [17], and sexual dysfunction [18].”
BackgroundCognitive Performance and Diabetic Retinopathy: What Your Eyes Can Reveal About Your Brain
Faria, A. C. R. D. A., Dall'Agnol, J. F., Gouveia, A. M., Paiva, C. I. D., Segalla, V. C., Ogata, F. E., & Baena, C. P. (2022) · Current Diabetes Reviews · doi:10.2174/1573399819666220805154638 · Cited by 5
Yokokawa, T., Sasaki, S., Sase, K., Yoshii, N., Yasuda, J., Hayashi, T., & Fujita, S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273056 · Cited by 4
Hayes‐Larson, E., Andrews, R. M., Kezios, K., Bercu, A., Rouanet, A., Helmer, C., Crane, P. K., Gibbons, L. E., Klinedinst, B. S., McEvoy, L. K., et al. (2025) · Epidemiology · doi:10.1097/ede.0000000000001859 · Cited by 4
“44 Diabetes status was classified using the measure available for each cohort; diabetes type was not captured in all cohorts, so we did not restrict on diabetes type, but the vast majority of diabetes in older adults is type 2.”
Diabetes mellitus and cognitive functioning in a Serbian sample
Djokic, B., Spitznagel, M. B., Pavlović, D. M., Janković, N., Parojčić, A., Ilić, V. L., & Djurovic, M. N. (2014) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2014.985190 · Cited by 4
Ma, S., Zhang, J., Zhao, G., Wu, C., & Sun, X. (2017) · Proceedings of the Human Factors and Ergonomics Society Annual Meeting · doi:10.1177/1541931213601687 · Cited by 4
Mergeani, A. C., Antochi, F. A., Rusu, O. C., Ciobotaru, A., Coclitu, C., & Băjenaru, O. (2015) · Europe PMC (PubMed Central) · Cited by 4
The Value of Insulin Degludec in Frail Older Adults with Type 2 Diabetes
Strain, W. D., Morgan, A. R., & Evans, M. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01162-3 · Cited by 4
Alaama, T. Y., Basheikh, M. A., Khiyami, A. M., Mutwalli, M., Batawi, S., & Watfa, G. (2016) · Journal of Aging Research and Lifestyle · doi:10.14283/jarcp.2016.120 · Cited by 4
Periodontics and Oral-Systemic Relationships: Diabetes
Glascoe, A., Brown, R. S., Robinson, G., & Hailu, K. (2016) · Journal of the California Dental Association · doi:10.1080/19424396.2016.12220963 · Cited by 4
Mustač, F., Galijašević, T., Podolski, E., Belančić, A., Matovinović, M., & Marčinko, D. (2023) · Diabetology · doi:10.3390/diabetology4040041 · Cited by 3
Driving Simulator Studies of the Effectiveness of Countermeasures to Prevent Wrong-Way Crashes
Boot, W. R., Charness, N. H., Mitchum, A. L., Roque, N. A., Stothart, C. R., & Barajas, K. G. (2015) · Cited by 4
α‑lipoic acid can greatly alleviate the toxic effect of AGES on SH‑SY5Y cells
Niu, G., Guo, J., Tian, Y., Zhao, K., Li, J., & Xiao, Q. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3477 · Cited by 4
“6‐fold of the normal population, respectively (3).”
Determining the Optimal Cognitive Screening Tool in Older People With Diabetes
Mordenfeld, N., Gayus, N., Azmon, M., Twito, O. G., Yahalom-Peri, T., Natovich, R., & Cukierman‐Yaffe, T. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00322 · Cited by 4
Research of Epidemic Big Data Based on Improved Deep Convolutional Neural Network
Wang, W. (2020) · Computational and Mathematical Methods in Medicine · doi:10.1155/2020/3641745 · Cited by 4
Diabetes and dementia: a common link or coincidental coexistence?
Manning, S. R. (2007) · Biomedical Reviews · doi:10.14748/bmr.v18.68 · Cited by 4
“diabetic status found that compared to non-diabetics, diabetics have both a greater risk and rate of cognitive decline (3).”
Window to the brain: Can retinopathy be used to assess cognitive function
Fergenbaum, J. H., Bruce, S. G., Lou, W. Y. W., Hanley, A. J., Greenwood, C. E., & Young, T. K. (2010) · Brain Injury · doi:10.3109/02699052.2010.523044 · Cited by 4
“The associations between a number of cardiovascular risk factors such as hypertension [1], obesity [2] and diabetes [3] and cognitive decline and dementia suggest a vascular aetiology for neurological disorders.”
BackgroundMahakaeo, S., Zeimer, H., & Woodward, M. (2011) · European Geriatric Medicine · doi:10.1016/j.eurger.2011.03.002 · Cited by 4
Diabetes Mellitus And The Brain: Special Emphasis To Cognitive Function
Sa, H. (2013) · International Journal of Diabetology & Vascular Disease Research · doi:10.19070/2328-353x-130007 · Cited by 3
“5-fold greater rate of decline in cognitive function compared to those without diabetes [60].”
BackgroundVascular Dementia and Cognitive Impairment
Seshadri, S. S., Economos, A., & Wright, C. B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-29544-4.00017-7 · Cited by 4
Han, C.-Y., Liu, J., Wan, F., Tian, M., Zhang, Y., He, Q., & Yin-chu, S. (2019) · PubMed Central · Cited by 4
Natovich, R., Gayus, N., Azmon, M., Michal, H., Twito, O. G., Yair, T., Raudoi, S., Kapra, O., & Cukierman‐Yaffe, T. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00348 · Cited by 4
Florez, H. J., Ruiz, J. G., & Munshi, M. N. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch57 · Cited by 4
Intranasal insulin enhances resting-state functional connectivity in Type 2 Diabetes
Zhang, Z., Novak, V., Novák, P., Mantzoros, C. S., Ngo, L. H., Lioutas, V., & Dai, W. (2025) · PLoS ONE · doi:10.1371/journal.pone.0324029 · Cited by 3
Barroso, C. V., Alvarado, J. M., & García, E. G. (2015) · The Spanish Journal of Psychology · doi:10.1017/sjp.2015.61 · Cited by 3
Wright, C. B., & Caunca, M. R. (2020) · Springer eBooks · doi:10.1007/978-3-030-49586-2_13 · Cited by 3
Diabetes Mellitus: A Review and Update
Venyo, A. K. G. (2023) · Journal of Ophthalmology Research Reviews & Reports · doi:10.47363/jorrr/2023(4)144 · Cited by 8
Brady, R. P., SHAH, A. S., Altaye, M., Redel, J. M., Beebe, D. W., & DiFrancesco, M. W. (2025) · NeuroImage Clinical · doi:10.1016/j.nicl.2025.103828 · Cited by 3
“…cognitive decline, dementia, and stroke are increasingly recognized as clinically important complications associated with type 2 diabetes and obesity in mid to late adulthood (Awad et al., 2004; Cukierman et al., 2005; Collaboration et al., 2010; Quaye et al., 2023; Jaakonmaki et al., 2022).”
Fat, fib, and forgetfulness: The interplay between adiposity, atrial fibrillation, and dementia
Burnham, T. S., Ranjan, R., Konstantinidis, K., Steinberg, B. A., & Bunch, T. J. (2025) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2025.07.006 · Cited by 3
Inoue, Y., Nakamura, A., Kondo, Y., Hamano, K., Satoh, S., & Terauchi, Y. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.483 · Cited by 3
“In addition, diabetes has been associated with a greater risk of cognitive decline and function.(10,11) Therefore, it is assumed that there will be increased difficulty among this population to continue frequent insulin therapy.”
BackgroundConditions That Can Promote Alzheimer’s
de la Torre, J. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-34057-9_12 · Cited by 4
Evaluation of Cognitive Functions of Individuals Older Than 65 With Diagnosis of Diabetes
Eskin, S. G., & Barutçu, C. D. (2018) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317518802453 · Cited by 3
Vascular Dementia and Cognitive Impairment
Seshadri, S. S., Caunca, M. R., & Rundek, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-69424-7.00018-1 · Cited by 3
Cognitive screening among older adults with diabetes across diverse clinic settings
Gupta, D., Wilhalme, H. M., Sauder, G., & Moin, T. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110184 · Cited by 4
Wang, X., Hui, X., Wang, X., Huang, B., Gan, X., Liu, X., Shen, Z., Sun, Y., & Li, L. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1222541 · Cited by 3
“5–2 times higher than that in patients without diabetes mellitus (Cukierman et al., 2005).”
BackgroundYue, Q., Meng, Z., Wang, L., Sun, Q., Wang, S., Li, J., & Liu, F. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110660 · Cited by 3
“A previous systematic review demonstrated that DM is a risk factor for mild cognitive dysfunction and dementia (Biessels et al., 2006; Cheng et al., 2012; Cukierman et al., 2005).”
Quality of Life in Type 2 Diabetes Mellitus Patients with Neuropsychological Deficits
Marneras, C., Messinis, L., Ntoskou, A., Nasios, G., Μαρτζούκου, Μ., & Papathanasopoulos, P. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-32637-1_5 · Cited by 3
The probable role of insulin resistance and SIRT1 proteins in the Alzheimer’s disease
Tural, R., Altan, N., İrkeç, C., Şahin, D., & Çağlayan, H. Z. B. (2020) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2020_133 · Cited by 3
“Kruskal‒Wallis and then Mann‒Whitney U tests were used for SIRT1, IGF-1, Aβ (1-42), TSH, T4, HDL-cholesterol, MMSE nonparametric parameters.”
BackgroundMethodInfluentialLi, R., Wang, X., Lawler, K., Garg, S., Bai, Q., & Alty, J. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2104.14073 · Cited by 3
“However, most of these require clinicians to interpret the results [11, 12, 13, 14] and are thus somewhat subjective.”
BackgroundCaruso, R., Santucci, A., Caruso, M. P., Pittella, F., Dellafiore, F., Corbetta, S., & Mosconi, E. (2015) · International Diabetes Nursing · doi:10.1179/2057332415y.0000000005 · Cited by 3
“Subjects with T2DM show a faster cognitive decline (CD) compared with healthy subjects.(3) Most of subjects with T2DM are over 65 years, and their lifestyles could be associated with the rate of CD, especially the dietary habits(4) and the physical activities.”
BackgroundLee, H., Yoon, J.-H., & Kim, S. (2007) · Journal of Life Science · doi:10.5352/jls.2007.17.11.1464 · Cited by 3
Buysschaert, M., Bordier, L., Bauduceau, B., Buysschaert, M., Floch, J. L., Verny, C., & Doucet, J. (2015) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(15)30010-9 · Cited by 3
Tiehuis, A. M., van den Berg, E., Kappelle, L. J., & Biessels, G. J. (2007) · Aging Health · doi:10.2217/1745509x.3.3.361 · Cited by 3
Launer, L. J., & Wright, C. B. (2009) · Springer eBooks · doi:10.1007/978-0-387-70715-0_14 · Cited by 3
Trongsakul, S. (2015) · PubMed Central · Cited by 3
Association of mild cognitive impairment with serum Vitamin D level in type 2 diabetes mellitus
Singh, K., Singh, V., Meena, B., Beniwal, S., Gaur, S., Ujwal, V., & Kumar, H. (2015) · Indian Journal of Health Sciences and Biomedical Research (KLEU) · doi:10.4103/2349-5006.174240 · Cited by 3
Studies of Anti-Diabetic Effect of Morinda citrifolia Fruit Juice on Alloxan Induced Diabetic Rat
Mishra, N. D. J. D. P., Rajurkar, A. K. B. S. R., & Ballurkar, B. V. (2017) · International Journal of Current Microbiology and Applied Sciences · doi:10.20546/ijcmas.2017.604.239 · Cited by 3
“5 fold greater rate of decline in cognitive function (Cukierman et al., 2005).”
BackgroundInfluentialIs there a Link between Physical, Cognitive and Fear of Falls among Elderly with Diabetes Mellitus?
Azizan, A., Anum, A., & Alias, A. (2019) · Journal of ASIAN Behavioural Studies · doi:10.21834/jabs.v4i13.333 · Cited by 3
Osama, A., Khalil, T. H., Negm, M., El-Razek, R. A., & Abouelhamd, H. (2020) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-020-00232-w · Cited by 3
Cardiovascular Disease and Neurocognitive Function
Waldstein, S. R., Wendell, C. R., Hosey, M. M., Seliger, S. L., & Katzel, L. I. (2019) · Springer eBooks · doi:10.1007/978-3-030-14895-9_6 · Cited by 3
Kanthi, A., Singh, D., Manjunath, N. K., & Nagarathna, R. (2022) · Clinical EEG and Neuroscience · doi:10.1177/15500594221089106 · Cited by 3
Xu, S., Yu, W., Zhang, X., Wang, W., & Wang, X. (2022) · Brain Research · doi:10.1016/j.brainres.2022.148012 · Cited by 3
Kim, C., Kim, M. J., & Park, C. G. (2019) · Korean Journal of Stress Research · doi:10.17547/kjsr.2019.27.1.1 · Cited by 3
Really small vascular disease of the brain
Nyquist, P., & Barzilay, J. I. (2011) · Neurology · doi:10.1212/wnl.0b013e3182447e7c · Cited by 3
Liu, Z., Huang, H., & Zhao, L. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01324-1 · Cited by 2
APOE Polymorphism, Obstructive Sleep Apnea, and Cognitive Function
Gara, E. M., Goya, T. T., Ferreira-Silva, R., Matheus, L., Jordão, R. M., de Araújo, M. L., Silva, A. J., Guerra, R. S., Lorenzi‐Filho, G., & Ueno, L. M. (2024) · Sleep Science · doi:10.1055/s-0044-1788286 · Cited by 2
“We speculate that the difference from our investigation may be explained by the fact that, in this previous study, 23 factors associated with cognitive decline, including higher BMI, diabetes mellitus, and smoking, 40,41 were signi fi cantlyhigher in the OSA group.”
ResultMeo, S. A., Alotaibi, M. S., Shaikh, N., & Alguwaihes, A. M. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1660384 · Cited by 2
Sikkandar, M. Y., Alenzy, S. M., Begum, S. S., Almousa, R., Almosa, J. A., Alotaibi, A. M. G., Aldhfayan, A. M., Alshehri, A. A., Alotaibi, T. A., & Alotaibi, Y. A. (2025) · Innovation and Emerging Technologies · doi:10.1142/s2737599425500380 · Cited by 2
Guo, N., Deng, Z., Sheng, K., Wang, X., Wang, S., & Hua, C. (2025) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2025.109034 · Cited by 2
Macronutrients and cognitive performance
Dye, L., Lamport, D. J., Boyle, N., & Hoyland, A. (2011) · Elsevier eBooks · doi:10.1533/9780857092922.2.131 · Cited by 2
Lu, K., Li, M., McGee, K. H., Phillips, C. M., Yuan, J., & Sutton, S. S. (2016) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2015-0006 · Cited by 2
Quantitative susceptibility mapping in a diabetes mellitus rat model: Iron accumulation in the brain
Yoon, S., Park, S., Kim, H., Park, T., Kim, S. M., Hwang, Y., Kim, G. Y., Ryu, C., Yoon, T., & Jahng, G. (2017) · International Journal of Imaging Systems and Technology · doi:10.1002/ima.22229 · Cited by 2
“Diabetes mellitus is a common metabolic disease, which increases the risks of developing micro- and macro-vascular complications.(1,2) Diabetes alters the vascular endothelial function and permeability of the blood-brain barrier, diminishing regional cerebral perfusion and vasoreactivity.”
BackgroundCarmienke, S., Geier, A.-K., Deutsch, T., Rasche, F. M., & Frese, T. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0803-0362 · Cited by 2
“This is why the authors suggest that dementia should be classified as chronic complication of DM [45].”
BackgroundQuantitative Electroencephalography Findings in Patients With Diabetes Mellitus
Öksüz, Ö., Günver, M. G., & Arıkan, M. K. (2021) · Clinical EEG and Neuroscience · doi:10.1177/1550059421997657 · Cited by 2
“6-time increase in the risk of dementia were demonstrated in patients diagnosed with DM.(5) Brain atrophy, especially observed in the hippocampus, is known to be associated with cognitive impairment.”
BackgroundDementia Is Induced via the AGEs/Iba1/iNOS Pathway in Aged KK-Ay/Tajcl Mice
Hiramoto, K., Imai, M., Tanaka, S., & Ooi, K. (2023) · Life · doi:10.3390/life13071540 · Cited by 2
Use of Technologies at the Advanced Age
Sy, S. L., Sinclair, A. J., Munshi, M. N., Kahkoska, A. R., Weinstock, R. S., & Cukierman‐Yaffe, T. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.2511 · Cited by 2
“Diabetes may be viewed as a disease of accelerated aging because it is a risk factor for cognitive dysfunction (3), dementia (4–6), depression (7), physical disability, frailty, and sarcopenia (8–14).”
Li, P., Abuloha, S., Alshehri, A., Alkhuzam, K. A., Jaffee, M. S., Ospina, N. S., & Shao, H. (2025) · Healthcare and Rehabilitation · doi:10.1016/j.hcr.2024.100008 · Cited by 3
Shima, T., Onishi, H., & Terashima, C. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.109937 · Cited by 2
Wang, L., Dong, S., Zhao, C., Gao, Z., Jiang, L., Zhang, R., Shen, T., Guo, Y., Zhou, H., & Xu, S. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14010 · Cited by 4
Diabetes Mellitus and Neurocognitive Dysfunction
Ryan, C. M. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00095-4 · Cited by 2
Estimation of thyroid profile in patients with diabetes mellitus in New Civil Hospital, Surat
Vaghasiya, K., Patel, C., Shahane, K., Gamit, N., Zala, A., & Shah, A. (2015) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20150377 · Cited by 2
Health risks in undiagnosed or poorly-controlled diabetes
Nazarko, L. (2011) · British Journal of Healthcare Assistants · doi:10.12968/bjha.2011.5.10.479 · Cited by 2
Saji, N., Ichiyama, T., Tadano, M., Shimizu, H., Kawarai, T., Kita, Y., & Yokono, K. (2010) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2010.00639.x · Cited by 2
Analysis of cognitive disorders in older people with diabetes – preliminary study
Kozieł, A., Pierzak, M., Wychowaniec, M., & Głuszek, S. (2016) · Medical Studies · doi:10.5114/ms.2016.58802 · Cited by 2
“[9] proposed classifying the decline in cognitive efficiency in the group of chronic diabetes complications.”
BackgroundManagement of Diabetes in Elderly
Bauduceau, B., & Bordier, L. (2017) · International Journal of Medicine and Surgery · doi:10.15342/ijms.v4is.137 · Cited by 2
Evaluation of the injured eye.
Selezinka, W. (1988) · PubMed Central · Cited by 2
Parthasarathi, G., Varghese, A., Undela, K., & Gopalakrishna, N. (2017) · International Journal of Health & Allied Sciences · doi:10.4103/ijhas.ijhas_167_16 · Cited by 2
“6–3‐fold increased risk of producing Alzheimer’s type dementia and vascular dementia.[16] It was observed that CoI was more prevalent in elderly diabetic women and no association was observed with elderly diabetic men.”
BackgroundHeller, P. L., Briones, D. F., WILCOX, J. A., & de la Rosa, J. M. (2019) · International Journal of Neurodegenerative Disorders · doi:10.23937/2643-4539/1710008 · Cited by 2
“A number of studies have linked Parkinson’s disease (PD) [1-4] and diabetes [5-11] to cognitive impairment (CImp).”
BackgroundEffect of dipeptidyl peptidase-4 inhibitors inhibitor on cognitive dysfunction in diabetes
Liu, S., Wang, X., Deng, H., Xia, Y., Yang, X., & Chen, Q. (2020) · Medicine · doi:10.1097/md.0000000000020707 · Cited by 2
Zhu, L., Xiang, J., Wang, Q., Wang, A., Li, C., Tian, G., Zhang, H., & Chen, S. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.617136 · Cited by 2
Behavioural evaluation of mouse models of type 2 diabetes
Hitchen, B., Norwood, K., Gault, V. A., & Leslie, J. C. (2021) · Learning and Motivation · doi:10.1016/j.lmot.2021.101730 · Cited by 4
Mahmoud, A. A., Mohammad, N. A., & Soliman, A. S. (2021) · Zagazig University Medical Journal · doi:10.21608/zumj.2021.107835.2419 · Cited by 1
Role of Yoga in Prevention and Management of Type 2 Diabetes Mellitus (T2DM) and Its Complications
Metri, K., Nagaratna, R., & Singh, A. (2022) · Springer eBooks · doi:10.1007/978-981-16-6913-2_16 · Cited by 2
Evaluation of some Herbal Agents in the treatment of Diabetes in Comparison to Insulin
Al-Musawi, J. F. H. (2023) · Bionatura · doi:10.21931/rb/css/2023.08.03.49 · Cited by 2
“In addition, no adverse effects were observed during a limited evaluation of MCP's toxicity in rats and mice (5).”
L’internista ospedaliero nella gestione del paziente diabetico complesso
Magnani, G. E. L., Beltramello, G., Brancato, D., Fontanella, A., & Nardi, R. (2018) · Italian Journal of Medicine · doi:10.4081/itjm.q.2018.2 · Cited by 2
Hemoglobin A1c and 10-year information processing speed in Japanese community dwellers
Otsuka, R., Nishita, Y., Tange, C., Tomida, M., Ando, F., & Shimokata, H. (2019) · Environmental Health and Preventive Medicine · doi:10.1186/s12199-019-0778-8 · Cited by 2
Grammes, J., & Kubiak, T. (2020) · Der Diabetologe · doi:10.1007/s11428-020-00583-1 · Cited by 2
Itotani, K., Ueda, Y., Murata, S., SAITO, T. K., & Ono, R. (2020) · Topics in Geriatric Rehabilitation · doi:10.1097/tgr.0000000000000286 · Cited by 2
Chua, F. Y., Novakovic, Z. M., & Grasso, P. (2021) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-021-10248-2 · Cited by 2
Hunt, K. F., Cheah, Y. S., & Amiel, S. A. (2011) · Wiley eBooks · doi:10.1002/9781444347319.ch9 · Cited by 2
Metadata
- Authors
- Cukierman, T., Gerstein, H. C., & Williamson, J. D.
- Affiliations
- Population Health Research Institute (CA)
- Wake Forest University Health Sciences (US)
- Corresponding author
- Cukierman, T.
- Venue
- Diabetologia
- Published
- 2005-11-08
- Volume
- 48
- Issue
- 12
- Pages
- 2460-2469
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2046949772
- Cited by
- 1,049
- References
- 90
- Citations by year
- 2026: 23 · 2025: 47 · 2024: 37 · 2023: 56 · 2022: 72 · 2021: 58 · 2020: 62 · 2019: 70 · 2018: 54 · 2017: 61 · 2016: 65 · 2015: 67 · 2014: 77 · 2013: 64 · 2012: 43
- FWCI
- 2.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- diabetes mellitus, cognitive decline, dementia, cognitive function, Mini-Mental State Examination, Digit Symbol Substitution Test, chronic complications of diabetes, longitudinal cohort
- MeSH terms
- Cognition, Cognition Disorders, Dementia, Diabetes Mellitus, Follow-Up Studies, Humans, Intelligence Tests, Longitudinal Studies, Neuropsychological Tests, Prospective Studies, Risk Factors, Odds Ratio, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
